Cipher Pharma Balance Sheet - Annual (NASDAQ:CPHR)

Add to My Stocks
$2.99 $0 (0%) CPHR stock closing price Dec 08, 2016 (Closing)

A thorough fundamental analysis involves using data from Cipher Pharma balance sheet, apart from other financial statements, to value the business. As in our Cipher Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every year along with its annual results. Apart from analyzing Cipher Pharma revenue Cipher Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Cipher Pharma balance sheet for 2015 shows cash on hand of $27.18M. The company has a debt to equity ratio of .

View latest 10 year balance sheet data to check Cipher Pharma financial performance.
show more
Fiscal year is Jan - Dec20152014
Cash27.18M47.68M
Marketable Securities--
Receivables16.3M12.97M
Inventory1.24M-
Raw Materials--
Work In Progress--
Finished Goods1.2M-
Notes Receivable--
Other Current Assets4.04M-
Total Current Assets
48.77M61.67M
Property Plant & Equipment--
Accumulated Depreciation--
Net Property Plant & Equipment
--
Investment & Advances--
Other Non-Current Assets--
Deferred Charges8.35M6.23M
Intangibles52.22M1.54M
Deposits & Other Assets--
Total Assets
109.64M69.48M
Notes Payable--
Accounts Payable13.35M10.19M
Current Portion Long-Term Debt--
Current Portion Capital Leases--
Accrued Expenses--
Income Taxes Payable--
Other Current Liabilities5.16M1.38M
Total Current Liabilities
18.52M11.58M
Mortgages--
Deferred Taxes/Income-1.05M
Convertible Debt--
Long-Term Debt34.57M-
Non-Current Capital Leases--
Other Long-Term Liabilities2.18M-
Total Liabilities
55.38M12.64M
Minority Interest--
Preferred Stock--
Common Stock Net14.94M12.88M
Capital Surplus4.36M2.63M
Retained Earnings44.46M41.33M
Treasury Stock--
Other Liabilities-9.51M-
Shareholders Equity54.25M56.84M
Total Liabilities & Shareholders Equity109.64M69.48M
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Taro Pharma financial analysis

Most investors just check the Cipher Pharma stock price, and Cipher Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Cipher Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the Cipher Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Cipher Pharma had total assets of $109.64M.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Cipher Pharma is $55.38M. Shareholders' equity comes under liabilities as it is money the company owes the holders of CPHR stock.

Cipher Pharma Balance Sheet - Key Ratios